Investigating drug safety in pregnancy based on the German Pharmacoepidemiological Research Database (GePaRD): A proof‐of‐concept analysis on the association between valproate and spina bifida
Pharmacoepidemiology and Drug Safety2022Vol. 32(2), pp. 148–157
Citations Over TimeTop 10% of 2022 papers
Ulrike Haug, Bianca Kollhorst, Tania Schink, Kathrin Thöne, Katarina Dathe, Christof Schaefer, Marlies Onken
Abstract
Our proof-of-concept analysis based on GePaRD showed a strong association between intrauterine exposure to VPA and occurrence of spina bifida. The results are plausible and consistent with the literature, supporting the suitability of GePaRD and the developed algorithms to conduct studies on drug safety in pregnancy.
Related Papers
- → Mobility guidelines for the care of people with spina bifida(2020)18 cited
- → Gambaran Kasus Spina Bifida di RSUD Arifin Achmad Provinsi Riau Periode 2015-2017(2021)3 cited
- → Medical care of adults with spina bifida(2009)7 cited
- → СУЧАСНІ АСПЕКТИ РЕАБІЛІТАЦІЇ ДІТЕЙ ІЗ SPINA BIFIDA(2019)1 cited
- → The Self Concept of Adolescents with Spina Bifida(1985)8 cited